2012
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
More poor women get mammograms with counseling
REUTERS HEALTH
Tremelimumab monotherapy ineffective for advanced colorectal cancer
Anastrozole may be more effective in thinner women
Cancer survivors are often parents of youngsters
Sorafenib shows some benefit in head and neck cancer
Cell phone towers not linked to childhood cancer
REUTERS
Prior radiation increases complications after prostatectomy
Breast cancer kills more uninsured black women
First-line gefitinib slows EGFR-mutated lung cancer progression
Coffee may cut risk of head and neck cancers
Doxorubicin/carboplatin helpful in relapsed ovarian cancer
Pfizer pulls leukemia drug from U.S. market
Sentinel node micrometastases do not mandate complete axillary node dissection
Untreated prostate cancer no death sentence
Cord blood transplants a viable option in leukemia
Zoledronic acid boosts survival in multiple myeloma patients
CORRECTION: Letrozole/goserelin is effective hormone therapy for premenopausal breast CA
Neratinib shows little activity against non-small-cell lung cancer
Paclitaxel combos useful as breast cancer adjuvant therapy
Scientists find genes linked to testicular cancer
Common blood pressure drugs may raise cancer risk
Mastectomy rates still declining across US
Gefitinib aids chemoradiotherapy in head and neck cancer
Adding test for cervical cancer raises costs: study
Bone metastasis, skeletal events predict poor prostate CA prognosis
Yttrium-90 radioembolization effective for neuroendocrine liver metastases
Beware of kidney risks with Avastin
Learning to relax, cope extends cancer survival
Breast cancer may change biology when it spreads to the liver
Radiotherapy prolongs survival with locally advanced prostate cancer
Drug fights tumors in advanced lung cancer
Cetuximab colon cancer failure challenges assumptions
Amgen drug cuts prostate cancer bone problem risk
Roche says bevacizumab (Avastin) helps in advanced ovarian cancer
When sentinel node is positive, leave other axillary nodes alone: study
Bristol drug extends survival in deadly skin cancer
Breast cancer drug extends lives: study
Novartis' Tasigna beats Gleevec in 18-month study
New test can predict return of prostate cancer
Physicists, medical researchers to team up on cancer
Glioblastoma multiforme vaccine shows promise
Genes, lifestyle pose separate breast cancer risks
Immunotherapy for tumors key topic at cancer meeting
Cancer will kill 13.2 million a year by 2030: U.N.
NEWS PROVIDED BY
CURE Media Group About Us | Contact Us | CMG Corporate | Cancer Continuum | Press | FAQs | Write for CURE
Advertise Media Kit | Reprints
Manage Subscription Services | Newsletters | Join the CURE Survey Panel | My Account
Legal Licensing | Terms of Use | Privacy Policy
© 2012 CURE Media Group. All rights reserved. SitemapCURE does not provide medical, diagnostic, or treatment advice.